The role of neuromuscular blocking drugs in early severe acute respiratory distress syndrome

Canadian Journal of Anesthesia

Volumn 59, Issue 1, 2012, Pages 105-108

  Needham, Craig J ^a   Brindley, Peter G ^a  

^a UNIVERSITY OF ALBERTA   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

CISATRACURIUM; NEUROMUSCULAR BLOCKING AGENT; PLACEBO;

ADULT RESPIRATORY DISTRESS SYNDROME; ARTERIAL OXYGEN TENSION; ARTICLE; CRITICALLY ILL PATIENT; DRUG INTERMITTENT THERAPY; FAILURE FREE SURVIVAL; HUMAN; MORTALITY; MULTIPLE ORGAN FAILURE; PATIENT MONITORING; PNEUMOTHORAX; POSITIVE END EXPIRATORY PRESSURE; PRACTICE GUIDELINE; PRIORITY JOURNAL; RISK BENEFIT ANALYSIS; SEVERE ACUTE RESPIRATORY SYNDROME; TIDAL VOLUME; TREATMENT OUTCOME; WEAKNESS;

EID: 84856958231     PISSN: 0832610X     EISSN: 14968975     Source Type: Journal    
DOI: 10.1007/s12630-011-9615-2     Document Type: Article

References (12)

1. LB Ware MA Matthay 2000 The acute respiratory distress syndrome N Engl J Med 342 1334 1349 10793167 10.1056/NEJM200005043421806 1:STN:280: DC%2BD3c3jvFGhsw%3D%3D (Pubitemid 30408719)
2. MS Herridge CM Tansey A Matte, et al. 2011 Functional disability 5 years after acute respiratory distress syndrome N Engl J Med 364 1293 1304 21470008 10.1056/NEJMoa1011802 1:CAS:528:DC%2BC3MXkvVCnsr8%3D
3. AH Alsaghir CM Martin 2008 Effect of prone positioning in patients with acute respiratory distress syndrome: a meta-analysis Crit Care Med 36 603 609 18216609 10.1097/01.CCM.0000299739.98236.05 (Pubitemid 351158639)
4. AS Slutsky 2010 Neuromuscular blocking agents in ARDS N Engl J Med 363 1176 1180 20843254 10.1056/NEJMe1007136 1:CAS:528:DC%2BC3cXhtFOksL%2FF
5. S Raoof K Goulet A Esan DR Hess CN Sessler 2010 Severe hypoxemic respiratory failure: part 2-nonventilatory strategies Chest 137 1437 1448 20525656 10.1378/chest.09-2416
6. J Vender J Szokol GS Murphy M Nitsun 2004 Sedation, analgesia and neuromuscular blockade in sepsis: an evidence-based review Crit Care Med 32 S554 S561 15542964 10.1097/01.CCM.0000145907.86298.12 (Pubitemid 39489029)
7. S Deem CM Lee JR Curtis 2003 Acquired neuromuscular disorders in the intensive care unit Am J Respir Crit Care Med 168 735 739 14522811 10.1164/rccm.200302-191UP (Pubitemid 37188296)
8. RD Griffiths JB Hall 2010 Intensive care unit-acquired weakness Crit Care Med 38 779 787 20048676 10.1097/CCM.0b013e3181cc4b53
9. MJ Murray J Cowen H DeBlock, et al. 2002 Clinical practice guidelines for sustained neuromuscular blockade in the acult critically ill patient Crit Care Med 30 142 156 11902255 10.1097/00003246-200201000-00021 1:CAS:528: DC%2BD38XhtVyluro%3D (Pubitemid 34112189)
10. M Gainnier A Roch JM Forel, et al. 2004 Effect of neuromuscular blocking agents on gas exchange in patients presenting with acute respiratory distress syndrome Crit Care Med 32 113 119 14707568 10.1097/01.CCM.0000104114.72614.BC 1:CAS:528:DC%2BD2cXhtV2mtQ%3D%3D (Pubitemid 38125571)
11. JM Forel A Roch V Marin, et al. 2006 Neuromuscular blocking agents decrease inflammatory response in patients presenting with acute respiratory distress syndrome Crit Care Med 34 2749 2757 16932229 10.1097/01.CCM.0000239435. 87433.0D 1:CAS:528:DC%2BD28XhtV2rsrbJ (Pubitemid 44610939)
12. D Testelmans K Maes P Wouters, et al. 2006 Rocuronium exacerbates mechanical ventilation-induced diaphragm dysfunction in rats Crit Care Med 34 3018 3023 17012910 1:CAS:528:DC%2BD28Xht1CgtLnM (Pubitemid 44808747)